scholarly journals Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8+Cells by Fas/Fas-Ligand Interaction

2002 ◽  
Vol 2 ◽  
pp. 421-423 ◽  
Author(s):  
Francesco Puppo ◽  
Paola Contini ◽  
Massimo Ghio ◽  
Francesco Indiveri
2000 ◽  
Vol 61 (12) ◽  
pp. 1347-1351 ◽  
Author(s):  
Paola Contini ◽  
Massimo Ghio ◽  
Andrea Merlo ◽  
Sabrina Brenci ◽  
Gilberto Filaci ◽  
...  

1999 ◽  
Vol 60 (5) ◽  
pp. 414-423 ◽  
Author(s):  
Carin A Koelman ◽  
Wilma Ensink ◽  
Arend Mulder ◽  
Janneke Tanke ◽  
Ilias I.N Doxiadis ◽  
...  

1994 ◽  
Vol 180 (2) ◽  
pp. 545-555 ◽  
Author(s):  
A Moretta ◽  
M Vitale ◽  
S Sivori ◽  
C Bottino ◽  
L Morelli ◽  
...  

GL183 or EB6 (p58) molecules have been shown to function as receptors for different HLA-C alleles and to deliver an inhibitory signal to natural killer (NK) cells, thus preventing lysis of target cells. In this study, we analyzed a subset of NK cells characterized by a p58-negative surface phenotype. We show that p58-negative clones, although specific for class I molecules do not recognize HLA-C alleles. In addition, by the use of appropriate target cells transfected with different HLA-class I alleles we identified HLA-B7 as the protective element recognized by a fraction of p58-negative clones. In an attempt to identify the receptor molecules expressed by HLA-B7-specific clones, monoclonal antibodies (mAbs) were selected after mice immunization with such clones. Two of these mAbs, termed XA-88 and XA-185, and their F(ab')2 fragments, were found to reconstitute lysis of B7+ target cells by B7-specific NK clones. Both mAbs were shown to be directed against the recently clustered Kp43 molecule (CD94). Thus, mAb-mediated masking of Kp43 molecules interferes with recognition of HLA-B7 and results in target cell lysis. Moreover, in a redirected killing assay, the cross-linking of Kp43 molecules mediated by the XA185 mAb strongly inhibited the cytolytic activity of HLA-B7-specific NK clones, thus mimicking the functional effect of B7 molecules. Taken together, these data strongly suggest that Kp43 molecules function as receptors for HLA-B7 and that this receptor/ligand interaction results in inhibition of the NK-mediated cytolytic activity. Indirect immunofluorescence and FACS analysis of a large number of random NK clones showed that Kp43 molecules (a) were brightly expressed on a subset of p58-negative clones, corresponding to those specific for HLA-B7; (b) displayed a medium/low fluorescence in the p58-negative clones that are not B7-specific as well as in most p58+ NK clones; and (c) were brightly expressed as in the p58+ clone ET34 (GL183-/EB6+, Cw4-specific). Functional analysis revealed that Kp43 functioned as an inhibitory receptor only in NK clones displaying bright fluorescence. These studies also indicate that some NK clones (e.g., the ET34) can coexpress two distinct receptors (p58 and Kp43) for different class I alleles (Cw4 and B7). Finally, we show that Kp43 molecules function as receptors only for some HLA-B alleles and that still undefined receptor(s) must exist for other HLA-B alleles including B27.


1994 ◽  
Vol 10 (9) ◽  
pp. 1061-1064 ◽  
Author(s):  
FRANCESCO PUPPO ◽  
SABRINA BRENCI ◽  
ELEONORA MONTINARO ◽  
LORELLA LANZA ◽  
PAOLA CONTINI ◽  
...  

2008 ◽  
Vol 80 (6) ◽  
pp. 503-509 ◽  
Author(s):  
Anne-Sophie Moreau ◽  
Yasmine Sebti ◽  
Alain Duhamel ◽  
Aldo M. Roccaro ◽  
Valérie Coiteux ◽  
...  

Blood ◽  
1999 ◽  
Vol 93 (5) ◽  
pp. 1770-1777 ◽  
Author(s):  
M. Ghio ◽  
P. Contini ◽  
C. Mazzei ◽  
S. Brenci ◽  
G. Barberis ◽  
...  

Abstract The immunomodulatory effect of allogeneic blood transfusions (ABT) has been known for many years. However, a complete understanding of the effects of ABT on the recipient’s immune system has remained elusive. Soluble HLA class I (sHLA-I), HLA class II (sHLA-II), and Fas ligand (sFasL) molecules may play immunoregulatory roles. We determined by double-determinant immunoenzymatic assay (DDIA) sHLA-I, sHLA-II, and sFasL concentrations in different blood components. sHLA-I and sFasL levels in red blood cells (RBCs) stored for up to 30 days and in random-donor platelets are significantly (P < .001) higher than in other blood components and their amount is proportionate to the number of residual donor leukocytes and to the length of storage. Blood components with high sHLA-I and sFasL levels play immunoregulatory roles in vitro as in allogeneic mixed lymphocyte responses (MLR) and antigen-specific cytotoxic T-cell (CTL) activity, and induce apoptosis in Fas-positive cells. These data suggest that soluble molecules in blood components are functional. If these results are paralleled in vivo, they should be taken into account in transfusion practice. Blood components that can cause immunosuppression should be chosen to induce transplantation tolerance, whereas blood components that lack immunosuppressive effects should be preferred to reduce the risk of postoperative complications and cancer recurrence.


Blood ◽  
1999 ◽  
Vol 93 (5) ◽  
pp. 1770-1777 ◽  
Author(s):  
M. Ghio ◽  
P. Contini ◽  
C. Mazzei ◽  
S. Brenci ◽  
G. Barberis ◽  
...  

The immunomodulatory effect of allogeneic blood transfusions (ABT) has been known for many years. However, a complete understanding of the effects of ABT on the recipient’s immune system has remained elusive. Soluble HLA class I (sHLA-I), HLA class II (sHLA-II), and Fas ligand (sFasL) molecules may play immunoregulatory roles. We determined by double-determinant immunoenzymatic assay (DDIA) sHLA-I, sHLA-II, and sFasL concentrations in different blood components. sHLA-I and sFasL levels in red blood cells (RBCs) stored for up to 30 days and in random-donor platelets are significantly (P < .001) higher than in other blood components and their amount is proportionate to the number of residual donor leukocytes and to the length of storage. Blood components with high sHLA-I and sFasL levels play immunoregulatory roles in vitro as in allogeneic mixed lymphocyte responses (MLR) and antigen-specific cytotoxic T-cell (CTL) activity, and induce apoptosis in Fas-positive cells. These data suggest that soluble molecules in blood components are functional. If these results are paralleled in vivo, they should be taken into account in transfusion practice. Blood components that can cause immunosuppression should be chosen to induce transplantation tolerance, whereas blood components that lack immunosuppressive effects should be preferred to reduce the risk of postoperative complications and cancer recurrence.


Sign in / Sign up

Export Citation Format

Share Document